These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34250228)

  • 1. Brain Regional Differences in Hexanucleotide Repeat Length in X-Linked Dystonia-Parkinsonism Using Nanopore Sequencing.
    Reyes CJ; Laabs BH; Schaake S; Lüth T; Ardicoglu R; Rakovic A; Grütz K; Alvarez-Fischer D; Jamora RD; Rosales RL; Weyers I; König IR; Brüggemann N; Klein C; Dobricic V; Westenberger A; Trinh J
    Neurol Genet; 2021 Aug; 7(4):e608. PubMed ID: 34250228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in
    Lüth T; Laβ J; Schaake S; Wohlers I; Pozojevic J; Jamora RDG; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Schlüter K; Tse R; Reyes CJ; Brand M; Busch H; Klein C; Westenberger A; Trinh J
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat.
    Campion LN; Mejia Maza A; Yadav R; Penney EB; Murcar MG; Correia K; Gillis T; Fernandez-Cerado C; Velasco-Andrada MS; Legarda GP; Ganza-Bautista NG; Lagarde JBB; Acuña PJ; Multhaupt-Buell T; Aldykiewicz G; Supnet ML; De Guzman JK; Go C; Sharma N; Munoz EL; Ang MC; Diesta CCE; Bragg DC; Ozelius LJ; Wheeler VC
    Acta Neuropathol Commun; 2022 Apr; 10(1):49. PubMed ID: 35395816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
    Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
    Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset.
    Trinh J; Lüth T; Schaake S; Laabs BH; Schlüter K; Laβ J; Pozojevic J; Tse R; König I; Jamora RD; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Kaiser FJ; Depienne C; Pearson CE; Westenberger A; Klein C
    Brain; 2023 Mar; 146(3):1075-1082. PubMed ID: 35481544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of
    Capponi S; Stöffler N; Penney EB; Grütz K; Nizamuddin S; Vermunt MW; Castelijns B; Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Muñoz EL; Ang MA; Diesta CCE; Creyghton MP; Klein C; Bragg DC; De Rijk P; Timmers HTM
    Brain Commun; 2021; 3(4):fcab253. PubMed ID: 34746789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in
    Bragg DC; Mangkalaphiban K; Vaine CA; Kulkarni NJ; Shin D; Yadav R; Dhakal J; Ton ML; Cheng A; Russo CT; Ang M; Acuña P; Go C; Franceour TN; Multhaupt-Buell T; Ito N; Müller U; Hendriks WT; Breakefield XO; Sharma N; Ozelius LJ
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11020-E11028. PubMed ID: 29229810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked dystonia-parkinsonism: over and above a repeat disorder.
    Pozojevic J; Cruz JN; Westenberger A
    Med Genet; 2021 Dec; 33(4):319-324. PubMed ID: 38835428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism.
    D'Ignazio L; Jacomini RS; Qamar B; Benjamin KJM; Arora R; Sawada T; Evans TA; Diffenderfer KE; Pankonin AR; Hendriks WT; Hyde TM; Kleinman JE; Weinberger DR; Bragg DC; Paquola ACM; Erwin JA
    eNeuro; 2022 Jul; 9(4):. PubMed ID: 35868859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Glucocorticoids on
    Cruz SED; Bagamasbad P
    J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-Linked Dystonia-Parkinsonism: recent advances.
    Bragg DC; Sharma N; Ozelius LJ
    Curr Opin Neurol; 2019 Aug; 32(4):604-609. PubMed ID: 31116117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-quadruplexes in an SVA retrotransposon cause aberrant TAF1 gene expression in X-linked dystonia parkinsonism.
    Nicoletto G; Terreri M; Maurizio I; Ruggiero E; Cernilogar FM; Vaine CA; Cottini MV; Shcherbakova I; Penney EB; Gallina I; Monchaud D; Bragg DC; Schotta G; Richter SN
    Nucleic Acids Res; 2024 Oct; 52(19):11571-11586. PubMed ID: 39287133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
    Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
    Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
    Chin HL; Lin CY; Chou OH
    Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
    Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat-Associated Non-AUG Translation of AGAGGG Repeats that Cause X-Linked Dystonia-Parkinsonism.
    Reyes CJ; Asano K; Todd PK; Klein C; Rakovic A
    Mov Disord; 2022 Nov; 37(11):2284-2289. PubMed ID: 35971992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism.
    Pozojevic J; von Holt BH; Westenberger A
    Med Genet; 2022 Jun; 34(2):97-102. PubMed ID: 38835911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of Mosaic Divergent Repeat Interruptions in X-Linked Dystonia-Parkinsonism.
    Laß J; Lüth T; Schlüter K; Schaake S; Laabs BH; Much C; Jamora RD; Rosales RL; Saranza G; Diesta CCE; Pearson CE; König IR; Brüggemann N; Klein C; Westenberger A; Trinh J
    Mov Disord; 2024 Jul; 39(7):1145-1153. PubMed ID: 38616406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.
    Makino S; Kaji R; Ando S; Tomizawa M; Yasuno K; Goto S; Matsumoto S; Tabuena MD; Maranon E; Dantes M; Lee LV; Ogasawara K; Tooyama I; Akatsu H; Nishimura M; Tamiya G
    Am J Hum Genet; 2007 Mar; 80(3):393-406. PubMed ID: 17273961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP).
    Rosenkrantz JL; Brandorff JE; Raghib S; Kapadia A; Vaine CA; Bragg DC; Farmiloe G; Jacobs FMJ
    Proc Natl Acad Sci U S A; 2024 Aug; 121(33):e2401217121. PubMed ID: 39102544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.